Industrial Consultancy & Sponsored Research (IC&SR) , IIT Madras
Graphene based composite as solitary platform for sensing devices
Categories for this Invention
Categories: Chemistry & Chemical Analysis
Industry: Sensor Technology, Biomedical Devices, Diagnostics, Healthcare, Biotechnology
Applications: Medical diagnostics for measuring neurotransmitters (like dopamine), cholesterol levels, and glucose in blood, Wearable health monitoring devices, Laboratory equipment for biomedical research
Market: The graphene sensors Market was valued at US$ 162.473 M in 2020 & is expected to reach US$ 1,142.008 M in 2027, growing at a CAGR of 32.12% from 2020-2027.
Image Gallery
Problem Statement
- Detecting abnormal levels of dopamine, cholesterol, and glucose is crucial due to their impact on health, making it essential to monitor them within specific ranges.
- Electrochemical sensors are popular for their speed, cheap, ease, and sensitivity. Graphene’s properties makes it a choice in these sensors.
- Graphene-metal oxides combination improves sensor performance for separate dopamine, glucose, and cholesterol detection.
- Yet, there’s a need for a material that detects all three at once on one platform. Hence, there is a need of this patent disclosure.
Technology
- The present patent discloses a Graphene based composite as solitary platform for sensing devices. The Sensor technology represents a groundbreaking innovation in healthcare and biomedical diagnostics.
- By harnessing the power of graphene-metal oxide hybrids, this technology offers unparalleled capabilities in detecting vital biomarkers like dopamine, cholesterol, and glucose within the human body.
- It is a game-changer, enabling precise and simultaneous measurement of these components on a single platform, revolutionizing healthcare monitoring and research practices. This leads to a new era of accurate & accessible biomedical measurements.
Method:
A method for preparing a graphene based composite comprising steps of:
- preparing Zn-SnO2 nanostructures by hydrothermal treatment using (Zn(CH3COO)2.2H2O & SnCl2.2H2O salts as precursor in a solvent containing ethanol & HCl,
- adding Zn-SnO2 nanostructures, ammonia and hydrazine hydrate to the GO (graphene oxide) dispersion,
- stirring the resulting dispersion at the room temperature, transferring it to a Teflon-lined autoclave & treating it hydrothermally.
- A graphene based composite for use in sensing of dopamine, cholesterol, and glucose in real time with error percentage of less than 2%.
Key Features / Value Proposition
User Perspective:
- Simultaneously detects dopamine, cholesterol, and glucose in real-time for comprehensive health insights.
- Same electrode can be efficiently used for sequential detections, enhancing usability in clinical settings.
- High-accuracy, reproducible & correlation with clinical data make it a reliable tool for disease diagnosis and monitoring.
Industrial Perspective:
- Fills a market gap with a cost-effective solution for three-component detection in healthcare and diagnostics.
- Incorporation of metal oxide boosts overall sensing performance, positioning it as an innovative solution in electro-chemical sensing technology.
- Ability to use the same electrode for multiple detections contributes to cost-effectiveness for industrial applications.
Technical Perspective:
- Leverages Graphene-Metal Oxide Synergy, overcoming limitations and enhancing electrochemical properties.
- Hydrothermal synthesis ensures a simple and reproducible manufacturing process, and maintaining consistency.
- Demonstrates high sensitivity & selectivity, validated by comprehensive characterization using various techniques.
Questions about this Technology?
Contact For Licensing
sm-marketing@imail.iitm.ac.in
ipoffice2@iitm.ac.in
Research Lab
Prof. Ramaprabhu S
Department of Physics
Intellectual Property
- IITM IDF No: 1475
- Patent No: 391850
- PCT No.: PCT/IN2018/050435
Technology Readiness Level
TRL – 4
Experimentally validated in lab.